Biotricity annual operating margin
2022
2023
2024
2025
2026
Biotricity's operating margin was 10.57% for fiscal 2026.
View full Biotricity company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2026 | 2026-03-31 | 10.57% | +28.33 pp |
| 2025 | 2025-03-31 | −17.76% | +55.42 pp |
| 2024 | 2024-03-31 | −73.18% | +86.68 pp |
| 2023 | 2023-03-31 | −159.87% | +58.91 pp |
| 2022 | 2022-03-31 | −218.77% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2027 | 2026-06-30 | 3.70% | −3.58 pp |
| Q4 2026 | 2026-03-31 | 16.34% | +39.44 pp |
| Q3 2026 | 2025-12-31 | 11.06% | +15.73 pp |
| Q2 2026 | 2025-09-30 | 7.05% | +16.46 pp |
| Q1 2026 | 2025-06-30 | 7.28% | +42.16 pp |
| Q4 2025 | 2025-03-31 | −23.10% | +72.68 pp |
| Q3 2025 | 2024-12-31 | −4.67% | +38.45 pp |
| Q2 2025 | 2024-09-30 | −9.42% | +66.18 pp |
| Q1 2025 | 2024-06-30 | −34.88% | +41.80 pp |
| Q4 2024 | 2024-03-31 | −95.78% | +30.15 pp |
| Q3 2024 | 2023-12-31 | −43.11% | +112.97 pp |
| Q2 2024 | 2023-09-30 | −75.59% | +93.59 pp |
| Q1 2024 | 2023-06-30 | −76.69% | +122.17 pp |
| Q4 2023 | 2023-03-31 | −125.93% | +119.41 pp |
| Q3 2023 | 2022-12-31 | −156.09% | — |
| Q2 2023 | 2022-09-30 | −169.19% | — |
| Q1 2023 | 2022-06-30 | −198.86% | — |
| Q3 2022 | 2021-12-31 | −245.34% | — |
Across the available reported history, Biotricity's operating margin increased from −17.76% to 10.57%, a change of +28.33 percentage points. The latest reported quarter, Q1 2027, shows 3.70%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Biotricity filings at SEC.gov ↗